Target intelligence / Profile preview

VENT homeobox pseudogene 2 (VENTXP2)

Target
VENTXP2
Molecular classification
Other (pseudogene), member of the VENT homeobox gene family
01

Overview

VENTXP2 is a member of the VENT homeobox gene family and is classified as a pseudogene, meaning it is a non-functional genomic sequence derived from a once-protein-coding gene. Pseudogenes generally result from duplication or retrotransposition events and typically lack necessary regulatory sequences or accumulate disabling mutations such as frameshifts or premature stop codons. VENTXP2 does not produce a functional protein and, unlike its functional family member VENTX, does not act as a transcription factor, nor is it involved in development or disease. The confusion may arise from the similarity to VENTX, which is a functional homeobox gene implicated in hematopoiesis and leukemia, but VENTXP2 itself lacks any known biological function, role in disease, or therapeutic relevance. VENTXP2’s gene locus is located on chromosome 13q31.1. Note: If a functional VENTX homeobox gene target is intended, you should refer to “VENTX” and not “VENTXP2”; “VENTXP2” refers only to the pseudogene sequence and is not a drug/protein target.

Other names
VENT homeobox pseudogene 2VENTXP2VENTX2P2Ensembl: ENSG00000215037NCBI Gene: 100287345HGNC: 30901
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, VENTXP2 does not encode a functional protein and does not have documented biological functions in human physiology or disease)
04

Disease associations

None (there is no evidence VENTXP2 plays any role in disease; it is not known to have biomarkers or interact with drugs)

Beyond the preview

Go deeper on VENT homeobox pseudogene 2 (VENTXP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VENT homeobox pseudogene 2 (VENTXP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call